A Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid Tumors
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Colorectal Cancer|Esophagus Cancer|Gastric Cancer|Pancreas Cancer|Non-small Cell Lung Cancer|Breast Cancer|Bile Duct Cancer
Interventions: BIOLOGICAL: CEA-targeted CAR-T cells
Sponsor: Chongqing Precision Biotech Co., Ltd
Collaborators: Zhejiang University